Literature DB >> 7661276

Multiple enchondromas associated with spindle-cell hemangioendotheliomas. An overlooked variant of Maffucci's syndrome.

J C Fanburg1, J M Meis-Kindblom, A E Rosenberg.   

Abstract

Maffucci's syndrome is classically defined as the association of multiple enchondromas and hemangiomas. Spindle-cell hemangioendothelioma (SCH), a recently described vascular tumor of purported low malignant potential, has both cavernous hemangioma and Kaposi-like features. We report six patients with Maffucci's syndrome in whom all vascular lesions were SCH. The enchondromas involved the small and long tubular bones of the extremities in all of these patients; flat bones were also involved in three patients. The SCH usually arose in the extremities, distal to the knees and elbows. Five of the six patients had multiple and separate nodules of SCH, and in four patients there was recurrent or persistent SCH within 6 months to 4 years after initial removal. One patient also had a vascular tumor in the spleen mainly with features of a low-grade angiosarcoma with separate SCH-like foci. None of the SCH have metastasized within a follow-up period averaging 20 years. Five patients are alive 14 to 31 years after presentation. One patient died from metastatic dedifferentiated chondrosarcoma. The patient with the low-grade splenic angiosarcoma is alive approximately 2 years after diagnosis. Reappraisal of the older literature suggests that some of the vascular tumors occurring in Maffucci's syndrome, previously diagnosed as hemangiomas, may in fact be SCH. The apparent association between Maffucci's syndrome and SCH, the presence of SCH in other congenital syndromes, and the young patient age and multicentric distribution of SCH unassociated with Maffucci's syndrome raise the possibility that SCH may be a manifestation of a congenital mesodermal disorder with a genetic background related to Maffucci's syndrome. Although the behavior of SCH appears to be one of a locally recurrent or persistent multicentric lesion that does not metastasize, the association of SCH-like foci in a low-grade angiosarcoma of the spleen raises the possibility that SCH may rarely be associated with a higher grade lesion. Therefore, SCH, at least in the setting of Maffucci's syndrome, should be carefully monitored.

Entities:  

Mesh:

Year:  1995        PMID: 7661276     DOI: 10.1097/00000478-199509000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Spindle cell hemangioma reoccurrence in the hand: case report.

Authors:  Sylvia S Gray; Mahmoud A Eltorky; Roy F Riascos; Richard D Montilla
Journal:  Hand (N Y)       Date:  2012-06

2.  Maffucci's syndrome associated with spindle cell hemangioendothelioma.

Authors:  M Hisaoka; T Aoki; H Kouho; H Chosa; H Hashimoto
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

Review 3.  Enchondromatosis: insights on the different subtypes.

Authors:  Twinkal C Pansuriya; Herman M Kroon; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2010-06-26

Review 4.  Premalignant conditions of bone.

Authors:  Andrew Horvai; K Krishnan Unni
Journal:  J Orthop Sci       Date:  2006-07       Impact factor: 1.601

Review 5.  Sclerosing angiomatoid nodular transformation of the spleen in a patient with Maffucci syndrome: a case report and review of literature.

Authors:  Xiao-Dan Huang; Hao-Sen Jiao; Zheng Yang; Chuang-Qi Chen; Yu-Long He; Xin-Hua Zhang
Journal:  Diagn Pathol       Date:  2017-11-10       Impact factor: 2.644

6.  Peritoneal cavernous hemangiomatosis: A case report.

Authors:  Li-Yuan Fu; Hong-Yu Chen; Xiao-Li Diao; Zhen-Jun Wang
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

7.  Spindle cell hemangioma of the spleen: A case report.

Authors:  Bing-Qiang Gao; Dong-Kai Zhou; Xiao-Hui Qian; Wang Zhang; Li-Xiong Ying; Wei-Lin Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 8.  Benign Bone Tumors: An Overview of What We Know Today.

Authors:  Sara De Salvo; Vito Pavone; Sebastiano Coco; Eleonora Dell'Agli; Chiara Blatti; Gianluca Testa
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

9.  Spindle Cell Hemangioendothelioma: Rare Clinical Entity.

Authors:  Kapil Dev Das; Kaushik Ghosh; Chinmoy Kar; Ramesh Chandra Gharami; Sisir Chakraborty; Ambarish Bhattacharyya
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

10.  Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.

Authors:  Yi Sun; Xindong Fan; Yamin Rao; Zhenfeng Wang; Deming Wang; Xitao Yang; Lianzhou Zheng; Mingzhe Wen; Ren Cai; Lixin Su
Journal:  Hereditas       Date:  2022-01-18       Impact factor: 3.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.